CRISPR/Cas9 gene editing is a rapidly developing technique that is thought to provide revolutionary new ways to manipulate genes for the treatment of a number of diseases. Delivering the CRISPR therapeutic in an efficient, safe and predictable way, though, has been difficult--to this end, researchers at Umass have created a means of administering the gene editor that could help send it to clinical trials.
A team of researchers in Massachusetts is developing a two-in-one nanoparticle that delivers both a photodynamic therapy and a molecular therapy to treat highly resistant tumors--such as those associated with pancreatic cancer--with decreased toxicity.
Researchers at the University of North Carolina have developed a method of drug delivery using exosomes to protect cancer drugs in the body before they reach their target, effectively cutting the necessary dose.
BOULDER, CO: January 12, 2016. Robert M. Di Scipio, Esq., CEO of Skyland Analytics, says the firm now offers a targeted set of risk management services for Life Science manufacturers. According to Di...